SINTSintx Technologies, Inc.
- Analyst Upgrades
Ascendiant Capital Maintains Buy on SINTX Technologies, Raises Price Target to $12.5
Ascendiant Capital analyst Edward Woo maintains SINTX Technologies with a Buy and raises the price target from $12 to $12.5. ...
- GlobeNewswire
SINTX Technologies Announces Silicon Nitride Masterclass with Leading Orthopedics Experts
Experts in implant retrieval, biomaterials and clinical practice examine the science, clinical experience and potential advantages of silicon nitride relative to established implant materials in Company-sponsored ...
- GlobeNewswire
SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
SALT LAKE CITY, Utah, Sept. 08, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics and biomaterials company commercializing proprietary ...
- GlobeNewswire
SINTX Technologies Regains Compliance with Nasdaq Stockholders’ Equity Requirement
SALT LAKE CITY, Utah, Aug. 13, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), a company focused on advanced silicon nitride materials and medical ...
- GlobeNewswire
SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth Initiatives
SALT LAKE CITY, Utah, Aug. 11, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), a leader in advanced silicon nitride biomaterials and ceramics for medical and ...
- GlobeNewswire
SINTX Technologies Announces Second Quarter 2026 Earnings Release Date and Webcast
SALT LAKE CITY, Utah, July 28, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), a leader in advanced silicon nitride ceramics and advanced material ...
- GlobeNewswire
SINTX Technologies Engages Veteran MedTech Executive Chris Lyons and Southern Metrics to Establish Strategic Opportunity Management Program
SALT LAKE CITY, Utah, July 23, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), a leader in advanced biomaterials and silicon nitride technologies for medical ...
- GlobeNewswire
SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders
SALT LAKE CITY, Utah, June 22, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), a leader in advanced silicon nitride ceramics and advanced material ...
- Analyst Upgrades
Maxim Group Reinstates Buy on SINTX Technologies, Announces $6 Price Target
Maxim Group analyst Anthony Vendetti reinstates SINTX Technologies with a Buy and announces $6 price target. ...
- GlobeNewswire
SINTX Technologies Announces Raise of Approximately $5.0 Million of Capital, Including a $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
SALT LAKE CITY, Utah, June 03, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced biomaterials company focused on developing silicon nitride technologies for medical ...
- Analyst Upgrades
HC Wainwright & Co. Reiterates Buy on SINTX Technologies, Maintains $10 Price Target
HC Wainwright & Co. analyst Brandon Folkes reiterates SINTX Technologies with a Buy and maintains $10 price target. ...
- Analyst Upgrades
HC Wainwright & Co. Initiates Coverage On SINTX Technologies with Buy Rating, Announces Price Target of $10
HC Wainwright & Co. analyst Brandon Folkes initiates coverage on SINTX Technologies with a Buy rating and announces Price Target of $10. ...
- Analyst Upgrades
Ascendiant Capital Maintains Buy on SINTX Technologies, Lowers Price Target to $12
Ascendiant Capital analyst Edward Woo maintains SINTX Technologies with a Buy and lowers the price target from $16 to $12. ...
- GlobeNewswire
SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution
Clinical milestone, new President appointment, and platform expansion position SINTX for commercial rollout and revenue growth in 2026 SALT LAKE CITY, Utah, March 23, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. ...
- GlobeNewswire
SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms
Appointment supports acceleration of revenue opportunities from SiNERGY™ silicon nitride devices and antipathogenic fibrous material technologies SALT LAKE CITY, Utah, Feb. 18, 2026 (GLOBE NEWSWIRE) -- SINTX ...
- GlobeNewswire
SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5
SALT LAKE CITY, Utah, Jan. 29, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics and biomaterials company focused on silicon-nitride-based medical ...
- GlobeNewswire
SINTX Technologies to Participate in Sidoti & Company Investor Conference
SALT LAKE CITY, Utah, Dec. 08, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), today announced that management will be presenting at Sidoti & Company's Year End Virtual ...
- Analyst Upgrades
Ascendiant Capital Maintains Buy on SINTX Technologies, Lowers Price Target to $16
Ascendiant Capital analyst Edward Woo maintains SINTX Technologies with a Buy and lowers the price target from $25 to $16. ...
- GlobeNewswire
SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants
Milestone enables immediate production of SiN/PEEK custom devices SALT LAKE CITY, Utah, Dec. 01, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company"), an advanced ceramics and ...
- GlobeNewswire
SINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational Efficiencies
Company underscores its strengthened liquidity, cost reductions, and first revenue recorded from OsseoSculpt™ SALT LAKE CITY, Utah, Nov. 13, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ...
- GlobeNewswire
SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System
Clinical evaluation of the product by design surgeons completed, driving early commercial momentum SALT LAKE CITY, Utah, Nov. 03, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the ...
- GlobeNewswire
SINTX Technologies Receives FDA Clearance for SINAPTIC® Foot & Ankle Implant System
FDA cleared and U.S. manufactured implant system positions SINTX to enter billion-dollar U.S. market SALT LAKE CITY, Utah, Oct. 20, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the ...
- GlobeNewswire
UPDATE: SINTX Strengthens Infection-Prevention Portfolio with Newly Allowed U.S. Patent Covering $30 Billion Antipathogenic Addressable Market
New U.S. Patent reinforces competitive advantage and enables broader licensing and product opportunities across key markets SALT LAKE CITY, Utah, Oct. 16, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. ...
- GlobeNewswire
SINTX Technologies Strengthens IP Portfolio with New U.S. Patent Notice of Allowance Covering Antipathogenic Fabrics
New method patent expands SINTX's infection-prevention IP portfolio in $30 Billion Total Addressable Market U.S. Patent Notice of Allowance reinforces competitive advantage and enables broader licensing and product ...
- SEC
8-K Form - Current report, items 1.01 and 9.01 - Sintx Technologies, Inc. (0001269026) (Filer)
Current report, items 1.01 and 9.01 ...